SB 614 West Virginia Senate · 2025 Regular Session

Authorizing over-the-counter sale of Ivermectin

SB 614 would allow West Virginia pharmacists to sell Ivermectin for human use without a prescription once the federal Food and Drug Administration (FDA) approves it for over-the-counter sale. The bill requires pharmacists to provide the FDA-approved patient information sheet at the time of sale and eliminates the need for a pharmacist consultation. It also protects pharmacists and healthcare providers from liability or disciplinary action for dispensing or recommending Ivermectin under these conditions, provided they act in good faith and follow applicable laws. This change would directly affect patients seeking Ivermectin and pharmacists operating in West Virginia.
Bill status in committee 1 of 4 stages cleared
Introduction
Feb 2025
Committee Review
Floor Vote
Governor
Introduced Feb 27, 2025 Last action Mar 12, 2025
Maddy AI version diff · 1 comparison

What changed between versions

Introduced Version Committee Substitute · 4 edits
MODERATE
The bill was amended to add a new provision allowing pharmacists to dispense Ivermectin through collaborative pharmacy practice agreements, while retaining the over-the-counter dispensing provision that activates only after FDA approval. The bill also added an effective date provision and updated the title to reflect these expanded provisions.
Scope change
The bill's scope expanded to include collaborative pharmacy practice agreements as an additional method for dispensing Ivermectin, alongside the existing over-the-counter dispensing provision.
SCOPE

Added a new subsection (a) allowing pharmacists to provide Ivermectin pursuant to a collaborative pharmacy practice agreement with a non-patient-specific prescriptive order.

TIMELINE

Added a new subsection (e) establishing effective dates: 90 days from passage for most provisions, and immediately upon FDA approval for the over-the-counter dispensing provision.

TITLE

Updated the bill title to reflect the new collaborative pharmacy practice agreement provision and the FDA approval requirement for over-the-counter dispensing.

DEFINITION

Added a note clarifying that the bill enables two methods of dispensing Ivermectin: through collaborative agreements and without prescription after FDA approval.

Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
6
Key actions
1
Committee
4
Mar 12, 2025
Committee
To Judiciary
upper
Mar 12, 2025
Upper · Passed
Committee substitute reported, but first to Judiciary
upper
Feb 27, 2025
Committee
To Health and Human Resources
upper
Feb 27, 2025
Introduced
Introduced in Senate
upper
Feb 27, 2025
Committee
To Health and Human Resources then Judiciary
upper
1 primary · 10 co-sponsors

Sponsors